Accéder au contenu
Merck

Epidermal growth factor receptor expression in anal canal carcinoma.

American journal of clinical pathology (2005-06-01)
Lyly H Lê, Runjan Chetty, Malcolm J Moore
RÉSUMÉ

Most anal canal carcinomas (ACCs) are squamous cell carcinomas (SCCs). SCCs in other tumor sites strongly express epidermal growth factor receptors (EGFRs), the inhibition of which might result in favorable changes in tumor growth. A review of the published scientific literature reveals no information regarding the expression of EGFR in ACCs. Therefore, we obtained archived pathology samples from ACC biopsies and examined the frequency and level of expression of EGFR and other cell surface and cell cycle markers. The 21 samples studied universally and strongly expressed EGFR and were negative for HER-2. Clinical studies of EGFR inhibitors in advanced ACC are warranted.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
Pepsine from porcine gastric mucosa, powder, ≥400 units/mg protein